Inflammatory myopathy following COVID-19 mRNA vaccination in a patient with VEXAS syndrome

Affiliations

• ¹ Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan.
• ² Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
• ³ Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan, Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan.